Wakatsuki A, Ikenoue N, Okatani Y, Shinohara K, Watanabe K, Fukaya T
Department of Obstetrics and Gynecology, Kochi Medical School, Kochi, Japan.
Obstet Gynecol. 2001 Mar;97(3):333-7. doi: 10.1016/s0029-7844(00)01185-6.
To test whether hydrolysis of low-density lipoprotein (LDL) triglyceride by lipolytic enzymes decreases the size of LDL particles in women treated with estrogen replacement.
Fifteen postmenopausal women received 0.625 mg conjugated equine estrogens daily for 3 months. Plasma concentrations of total cholesterol, triglyceride, and high-density lipoprotein (HDL) cholesterol were measured before and after therapy. We also assayed levels of total, free, and esterified cholesterol, triglyceride, and protein in LDL. Plasma samples were incubated at 37C for 24 hours and LDL fractions were isolated by ultracentrifugation. After LDL samples were further incubated with or without lipoprotein lipase (500, 700, and 1000 ng/mL) at 37C for 24 hours, LDL triglyceride, LDL protein, and the diameter of LDL particles were measured.
Estrogen decreased total cholesterol and increased triglyceride and HDL cholesterol in plasma. Estrogen treatment decreased the ratio of cholesteryl ester/protein, whereas the ratio of triglyceride/protein increased. Estrogen decreased LDL particle diameter. Incubation of plasma increased the ratio of LDL triglyceride/protein from 0.40 +/- 0.14 to 0.48 +/- 0.15 (P <.05) and decreased the ratio of LDL cholesteryl ester/protein from 1.17 +/- 0.25 to 1.09 +/- 0.22 (P <.05), but LDL particle diameter did not change. Incubation of LDL with lipoprotein lipase reduced the LDL triglyceride/protein ratio, and decreased the diameter of LDL particles from 25.61 +/- 0.87 nm to 24.89 +/- 0.88 nm (500 ng/mL, P <.05), 24.62 +/- 1.20 nm (700 ng/mL, P <.05), and 24.67 +/- 1.19 nm (1000 ng/mL, P <.05).
In women treated with estrogen, hydrolysis of triglyceride in LDL particles might be accompanied by reduced particle size.
检测在接受雌激素替代治疗的女性中,脂解酶对低密度脂蛋白(LDL)甘油三酯的水解是否会减小LDL颗粒的大小。
15名绝经后女性每天服用0.625毫克共轭马雌激素,持续3个月。在治疗前后测量血浆总胆固醇、甘油三酯和高密度脂蛋白(HDL)胆固醇的浓度。我们还检测了LDL中总胆固醇、游离胆固醇、酯化胆固醇、甘油三酯和蛋白质的水平。血浆样本在37℃孵育24小时,通过超速离心分离LDL组分。在LDL样本分别与脂蛋白脂肪酶(500、700和1000纳克/毫升)或不与脂蛋白脂肪酶在37℃进一步孵育24小时后,测量LDL甘油三酯、LDL蛋白质和LDL颗粒的直径。
雌激素降低了血浆总胆固醇,增加了甘油三酯和HDL胆固醇。雌激素治疗降低了胆固醇酯/蛋白质的比例,而甘油三酯/蛋白质的比例增加。雌激素减小了LDL颗粒直径。血浆孵育使LDL甘油三酯/蛋白质的比例从0.40±0.14增加到0.48±0.15(P<.05),并使LDL胆固醇酯/蛋白质的比例从1.17±0.25降低到1.09±0.22(P<.05),但LDL颗粒直径没有变化。LDL与脂蛋白脂肪酶孵育降低了LDL甘油三酯/蛋白质的比例,并使LDL颗粒直径从25.61±0.87纳米减小到24.89±0.88纳米(500纳克/毫升,P<.05)、24.62±1.20纳米(700纳克/毫升,P<.05)和24.67±1.19纳米(1000纳克/毫升,P<.05)。
在接受雌激素治疗的女性中,LDL颗粒中甘油三酯的水解可能伴随着颗粒大小的减小。